Patents Assigned to QIAGEN Waltham, Inc.
  • Patent number: 10174066
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: January 8, 2019
    Assignee: QIAGEN WALTHAM, Inc.
    Inventors: Steven Gordon, Jerzy Olejnik
  • Patent number: 10160995
    Abstract: Methods and compositions for enriching a population of particles containing an analyte are disclosed. In one embodiment, enrichment beads are used that are larger in size than the beads used for amplification. A separation device is employed that can retain larger beads with bound amplified beads. The technique finds many uses, including enriching for beads with clonally amplified template, which can be used in a variety of assays, including nucleic acid sequencing.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: December 25, 2018
    Assignee: QIAGEN WALTHAM, INC.
    Inventors: Jerzy Olejnik, Steven Gordon, Martina Werner
  • Patent number: 10161000
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: December 25, 2018
    Assignee: QIAGEN WALTHAM, INC.
    Inventor: Jerzy Olejnik
  • Patent number: 10150994
    Abstract: Modular flow cells, devices with modular flow cells, and methods of sequencing using modular flow cells, as well as systems and kits including modular flow cells, are described, permitting sequencing wherein less than the full capacity for sequencing is desired.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: December 11, 2018
    Assignees: Qiagen Waltham, Inc., Qiagen Instruments AG
    Inventors: Jerzy Olejnik, Dirk Zimmermann
  • Patent number: 10036011
    Abstract: The present invention discloses methods of applications of indole-3-propionic acid, L-carnitine and O-acetyl-L-carnitine in one or more different reactive steps of a sequencing-by-synthesis workflow. The reactive steps employing these compounds include, but are not limited to, cleaving, imaging, incorporating bases and washing. The use of these new compounds provides improved sequencing performance including, but not limited to, lower error rates, higher sequence outputs and/or longer read lengths.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: July 31, 2018
    Assignee: QIAGEN Waltham, INC.
    Inventor: Luisa Andruzzi
  • Patent number: 9591268
    Abstract: Imagers and alignment methods for use by imagers imaging deoxyribonucleic acid (DNA) fragments on a flow cell are disclosed. The imagers capture intensity values at DNA fragment bead locations in tiles with each tile having a reference location in the flow cell. Flow cells may be aligned by obtaining a dark field image of each tile during a first imaging session, identifying dark field constellations of bead locations within two separate tiles during the first imaging session, identifying corresponding constellations during a second imaging session, altering the reference location of at least one tile during the second imaging session to correct for a linear offset in the corresponding constellations, and applying at least one correction factor for reading out intensity values from the imager for the bead locations in the flow cell to correct for an angular offset determined from offsets in the corresponding constellations.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 7, 2017
    Assignee: QIAGEN Waltham, Inc.
    Inventors: David Ray Stoops, Phillip Alan Veatch, Steven Jeffrey Gordon
  • Patent number: 9554095
    Abstract: Imagers and alignment methods for use by imagers imaging deoxyribonucleic acid (DNA) fragments on a flow cell are disclosed. The imagers capture intensity values at DNA fragment bead locations in tiles with each tile having a reference location in the flow cell. Flow cells may be aligned by obtaining a dark field image of each tile during a first imaging session, identifying dark field constellations of bead locations within two separate tiles during the first imaging session, identifying corresponding constellations during a second imaging session, altering the reference location of at least one tile during the second imaging session to correct for a linear offset in the corresponding constellations, and applying at least one correction factor for reading out intensity values from the imager for the bead locations in the flow cell to correct for an angular offset determined from offsets in the corresponding constellations.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 24, 2017
    Assignee: QIAGEN Waltham, Inc.
    Inventors: David Ray Stoops, Phillip Alan Veatch, Steven Jeffrey Gordon